LITTLE KNOWN FACTS ABOUT LINK ALTERNATIF MBL77.

Are BTK and PLCG2 mutations essential and sufficient for ibrutinib resistance in chronic lymphocytic leukemia?The existence of driver alterations is linked to fast development. Though a few alterations are enriched in CLL when compared to MBL, equally phases share the same driver composition. (Hal ini disampaikan Wira saat ditanya apakah ada kemung